Significant Agreements Juno Therapeutics Collaboration Agreement (Details)
$ in Thousands |
|
1 Months Ended |
3 Months Ended |
|
|
May. 26, 2015
item
|
May. 31, 2015
USD ($)
item
|
Mar. 31, 2016
USD ($)
|
Dec. 31, 2015
USD ($)
|
| Collaboration revenue |
|
|
$ 805
|
|
| Deferred revenue |
|
|
25,479
|
$ 25,321
|
| Accounts receivable |
|
|
1,108
|
$ 1,019
|
| Juno Therapeutics |
|
|
|
|
| Collaboration revenue |
|
|
800
|
|
| Deferred revenue |
|
|
25,500
|
|
| Accounts receivable |
|
|
1,000
|
|
| Collaboration and License Agreement | Juno Therapeutics |
|
|
|
|
| Number of research areas | item |
|
3
|
|
|
| Agreement term |
5 years
|
|
|
|
| Extensions | item |
2
|
|
|
|
| Extension period |
1 year
|
|
|
|
| Upfront fee received |
|
$ 25,000
|
|
|
| Potential research and development funding |
|
$ 22,000
|
|
|
| Number of additional licenses | item |
|
3
|
|
|
| Potential fee receivable for each gene target licensed |
|
$ 2,500
|
|
|
| Potential development milestone payments |
|
77,500
|
|
|
| Potential regulatory milestone payments |
|
80,000
|
|
|
| Potential commercial milestone payments |
|
$ 75,000
|
|
|
| Next possible milestone payment |
|
|
$ 2,500
|
|
| Number of options to purchase Development and Commercialization License | item |
|
3
|
|
|
| Number of deliverables | item |
|
6
|
|
|
| Number of accounting units | item |
|
11
|
|
|
| Number of accounting units for Development and Commercialization License | item |
|
3
|
|
|
| Number of accounting units for discount deliverables | item |
|
6
|
|
|
| Allocable arrangement consideration - upfront payment |
|
$ 25,000
|
|
|
| Allocable arrangement consideration - research support |
|
20,000
|
|
|
| Allocable arrangement consideration - specialized material costs |
|
2,000
|
|
|
| Allocable arrangement consideration - aggregate arrangement consideration |
|
47,000
|
|
|
| Allocable arrangement consideration - R&D Services Unit of Accounting |
|
16,700
|
|
|
| Allocable arrangement consideration - Development and Commercialization License for the first research area |
|
9,300
|
|
|
| Allocable arrangement consideration - Development and Commercialization License for the second research area |
|
15,400
|
|
|
| Allocable arrangement consideration - Development and Commercialization License for the third research area |
|
200
|
|
|
| Allocable arrangement consideration - first Discount Deliverable for the first research area |
|
700
|
|
|
| Allocable arrangement consideration - second Discount Deliverable for the first research area |
|
400
|
|
|
| Allocable arrangement consideration - third Discount Deliverable for the first research area |
|
200
|
|
|
| Allocable arrangement consideration - first Discount Deliverable for the second research area |
|
2,000
|
|
|
| Allocable arrangement consideration - second Discount Deliverable for the second research area |
|
1,300
|
|
|
| Allocable arrangement consideration - third Discount Deliverable for the second research area |
|
800
|
|
|
| Allocable arrangement consideration -JRC Deliverable |
|
$ 0
|
|
|